(Q36050544)

11 August 2017

1 reference

title

Recent developments in the diagnosis and monitoring of HBV infection and role of the genetic variability of the S gene (English)

1 reference

11 August 2017

Bernard Weber

1

1 reference

11 August 2017

publication date

1 January 2005

1 reference

Expert Review of Molecular Diagnostics: new diagnostic technologies are set to revolutionise healthcare

11 August 2017

published in

1 reference

11 August 2017

volume

5

1 reference

11 August 2017

issue

1

1 reference

11 August 2017

page(s)

75-91

1 reference

Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy.

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.1.75

Evaluation of two new automated assays for hepatitis B virus surface antigen (HBsAg) detection: IMMULITE HBsAg and IMMULITE 2000 HBsAg

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.1.75

Prevalence of isolated antibody to hepatitis B core antigen in an area endemic for hepatitis B virus infection: implications in hepatitis B vaccination programs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.1.75

Evaluation of the new automated enzymun-test anti-HBc plus for the detection of hepatitis B virus core antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.1.75

Hepatitis B virus markers in anti-HBc only positive individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.1.75

Occult hepatitis B virus infection: implications in transfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.1.75

Evaluation of an automated sample preparation protocol for quantitative detection of hepatitis C virus RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.1.75

Fully automated, internally controlled quantification of hepatitis B Virus DNA by real-time PCR by use of the MagNA Pure LC and LightCycler instruments

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.1.75

Hepatitis B virus (HBV) DNA assays (methods and practical use) and viral kinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.1.75

An international collaborative study to establish a World Health Organization international standard for hepatitis B virus DNA nucleic acid amplification techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.1.75

The risk of hepatitis B virus infection by transfusion in Kumasi, Ghana

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.1.75

Monitoring drug resistance in chronic hepatitis B virus (HBV)-infected patients during lamivudine therapy: evaluation of performance of INNO-LiPA HBV DR assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.1.75

Hepatitis B virus genotypes: comparison of genotyping methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.1.75

Serum HBV DNA as a marker of efficacy during therapy for chronic HBV infection: analysis and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.1.75

Automated multiplex assay system for simultaneous detection of hepatitis B virus DNA, hepatitis C virus RNA, and human immunodeficiency virus type 1 RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.1.75

Multicenter evaluation of a new automated fourth-generation human immunodeficiency virus screening assay with a sensitive antigen detection module and high specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.1.75

Hepatitis B virus sequence changes evolving in liver transplant recipients with fulminant hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.1.75

Mutant hepatitis B viruses: a matter of academic interest only or a problem with far-reaching implications?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.1.75

The influence of hepatitis B virus genotype on the development of lamivudine resistance during long-term treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.1.75

Multicenter evaluation of the VERSANT hepatitis B virus DNA 3.0 assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.1.75

Universal primers for real-time amplification of DNA from all known Orthohepadnavirus species

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.1.75

Real time TaqMan PCR detection and quantitation of HBV genotypes A-G with the use of an internal quantitation standard.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.1.75

Hepatitis B variant in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.1.75

Vaccine-induced escape mutant of hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.1.75

Survey of hepatitis B surface variant infection in children 15 years after a nationwide vaccination programme in Taiwan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.1.75

Predictions of the emergence of vaccine-resistant hepatitis B in The Gambia using a mathematical model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.1.75

Intra-familial evidence of horizontal transmission of hepatitis B virus surface antigen mutant G145R.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.1.75

Molecular epidemiology of hepatitis B virus vaccine variants in Singapore

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.1.75

Genetic variation of hepatitis B surface antigen coding region among infants with chronic hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.1.75

Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.1.75

The significance of 'anti-HBc only' in the clinical virology laboratory

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.1.75

Hepatitis B virus S mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.1.75

Genetic alterations in the S gene of hepatitis B virus in patients with acute hepatitis B, chronic hepatitis B and hepatitis B liver cirrhosis before and after liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.1.75

Fulminant reactivation of hepatitis B due to envelope protein mutant that escaped detection by monoclonal HBsAg ELISA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.1.75

A dominant hepatitis B virus population defective in virus secretion because of several S-gene mutations from a patient with fulminant hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.1.75

Isolation, characterization and biological significance of hepatitis B virus mutants from serum of a patient with immunologically negative HBV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.1.75

New hepatitis B virus mutant form in a blood donor that is undetectable in several hepatitis B surface antigen screening assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.1.75

Reactivity of 13 in vitro expressed hepatitis B surface antigen variants in 7 commercial diagnostic assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.1.75

Cloning and expression of surface antigens from occult chronic hepatitis B virus infections and their recognition by commercial detection assays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.1.75

Detection of HBs antigen in "anti-HBc alone" positive sera

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.1.75

The prevalence of surface antigen variants of hepatitis B virus in Papua New Guinea, South Africa, and Sardinia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.1.75

Precore and X region mutants in hepatitis B virus infections among renal dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.1.75

Evidence that anti-HBc but not HBV DNA testing may prevent some HBV transmission by transfusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.1.75

Infectivity of hepatic allografts with antibodies to hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.1.75

Effect of hepatitis B virus mutants on efficacy of vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.1.75

Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.1.75

Hepatitis B genotypes and the response to interferon therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.1.75

Changes of hepatitis B surface antigen variants in carrier children before and after universal vaccination in taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.5.1.75

21 January 2018

Identifiers

DOI

10.1586/14737159.5.1.75

1 reference

11 August 2017

1 reference